-

Feinstein Institutes Expert Outlines Plan for Advancing Behavioral Research

In a Nature Human Behaviour published letter, Dr. Karina Davidson describes a plan to foster discovery in behavioral research

MANHASSET, N.Y.--(BUSINESS WIRE)--In the field of behavioral medicine, progress has been seen as fragmented, often occurring by accident. In a letter to the editor published today in the journal Nature Human Behaviour, Karina W. Davidson, PhD, MASc, The Feinstein Institutes for Medical Research director of the Institute of Health System Science and national leader in behavioral change research, outlined how the Behavioral Medicine Research Council (BMRC) will progress the field of science.

The BMRC was formed in 2018 with members across the field of behavioral science's four main professional societies: Academy of Behavioral Medicine, American Psychosomatic Society, Society of Behavioral Medicine Research and Society for Health Psychology. Its mission is to develop a plan to foster scientific discovery in behavioral research by optimizing research practices, scaling and implanting programs and developing new interventions. It also addresses issues like funding, length of research projects and developing novel studies.

“We must bring together a far-reaching, comprehensive behavioral research community to effectively progress the field and significantly help patients,” said Dr. Davidson, Northwell Health’s senior vice president of research. “Through the BMRC, scientists from across the globe will work together to implement unique initiatives, inform policies and foster a new generation of forward-thinking investigators.”

In the letter, Dr. Davidson described three main points:

  • Use the right process: Taking a page from the United States Department of Defense’s Defense Advanced Research Projects Agency (DARPA) and the Gates Foundation, the science community needs to tackle and fund research for large-scale, systemic issues aggressively.
  • Incentivize the right behavior: National and international recognition, awards, along with collaborative competitions among scientists will help foster innovation.
  • Forge a path forward: Create a transparent public process and work in a joint effort between researchers and funding partners that will help bolster the field of science.

“As a respected leader in behavioral medicine, Dr. Davidson’s strategy will position the BMRC to have a significant impact on the future of behavioral research and health,” said Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes.

About the Feinstein Institutes
The Feinstein Institutes for Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we produce knowledge to cure disease, visit http://feinstein.northwell.edu and follow us on LinkedIn.

Contacts

Matthew Libassi
631-793-5325
mlibassi@northwell.edu

The Feinstein Institutes for Medical Research


Release Versions

Contacts

Matthew Libassi
631-793-5325
mlibassi@northwell.edu

More News From The Feinstein Institutes for Medical Research

Feinstein Institutes’ Dr. Stephanie Fitzpatrick elected Fellow of the Academy of Behavior Medicine Research

MANHASSET, N.Y.--(BUSINESS WIRE)--For her leadership in behavioral medicine and health equity, Stephanie L. Fitzpatrick, PhD, a clinical health psychologist, behavioral medicine researcher and implementation scientist at Northwell Health’s Feinstein Institutes for Medical Research, has been elected a Fellow of the Academy of Behavioral Medicine Research (ABMR), the premier honorary scientific organization in her field. The ABMR fellowship recognizes Dr. Fitzpatrick for her extensive contributio...

Northwell Invests in Mental Health, Opens Center for Psychedelics Research and Treatment

MANHASSET, N.Y.--(BUSINESS WIRE)--To address a pressing scientific and public need focused on the therapeutic potential and potential impairing effects of compounds like Δ9-THC (cannabis), psilocybin (mushrooms), MDMA (ecstasy) and ketamine, Northwell Health’s Feinstein Institutes for Medical Research today announced the official opening of the Center for Psychedelics Research and Treatment (CPRT) at Zucker Hillside Hospital in Glen Oaks. The Center will feature a state-of-the-art clinical lab,...

Northwell to Launch Long Island’s First Pancreas Transplant Program

MANHASSET, N.Y.--(BUSINESS WIRE)--Northwell Health has received approval to launch Long Island’s first adult pancreas transplant program, according to a letter from the New York State Department of Health (DOH). The Northwell Transplant Institute at North Shore University Hospital (NSUH) recently hosted a site visit with DOH officials, the final hurdle before opening the program to new patients. Northwell’s pancreas program will open access to patients across the greater New York and southern C...
Back to Newsroom